Nanotechnology Delivers a Two-Punch Combination With Big Potential for Patients With Rare Cancers

News Researchers at the Endocrine Oncology Branch of the National Cancer Institute (NCI) reported in the latest edition of the Journal of the National Cancer Institute (JNCI) that they were able to safely and effectively deliver a ... Contributed Author: CytImmune Sciences Inc. Topics: Oncology